| Literature DB >> 33050458 |
Xiaolan Xu1, Bo Yang2,3, Danfeng Wang4, Yuxuan Zhu2,3, Xiaoqing Miao3, Wenchao Yang1,3.
Abstract
Propolis has a very complex composition, with antibacterial, anti-inflammatory and other properties. To determine the composition of ethanol extracts of Brazilian green propolis (EEP-B) and their protective effect on mouse aortic endothelial cells (MAECs), the chemical composition of EEP-B was analysed by UPLC/Q-TOF-MS/MS, and the protective effect of EEP-B on the proliferation of lipopolysaccharide (LPS)-induced MAECs was determined by Cell Counting Kit-8 (CCK-8) assays. The protein levels of inflammatory cytokines tumour necrosis factor-α (TNF-α) and interleukin- 6 (IL-6) were measured by enzyme-linked immunosorbent assay (ELISA), and ICAM-1, VCAM-1 and MCP-1 expressions were analysed by western blotting. The results showed that a total of 24 compounds belonging to cinnamic acids and flavonoids, including 3,5-diisopentenyl-4-hydroxycinnamic acid (artepillin C), kaempferide, 3-isoprenyl p-coumaric acid, pinocembrin and 4'-methoxy pinobanksin, were identified in EEP-B. Among them, a new component, suggested to be 5-isoprenyl caffeic acid p-coumaric acid ester, was reported for the first time. The LPS-induced levels of TNF-α, IL-6, ICAM-1, VCAM-1 and MCP-1 were downregulated in response to 5, 10 and 20 μg/mL EEP-B. This study revealed that EEP-B could reduce LPS-induced inflammatory reactions, improve cell survival, and protect MAECs by regulating ICAM-1, VCAM-1 and MCP-1 expression. These findings could provide a theoretical basis for MAEC treatment using EEP-B.Entities:
Keywords: Brazilian green propolis; anti-inflammatory; chemical composition; mouse aortic endothelial cells
Mesh:
Substances:
Year: 2020 PMID: 33050458 PMCID: PMC7587206 DOI: 10.3390/molecules25204612
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chromatographic profile of 5-isoprenyl caffeic acid p-coumaric acid ester in Brazilian propolis.
Main components of the ethanol extracts of Brazilian propolis (EEP-B).
| No | tR (min) | λmax (nm) | Selected Ion | Formula | Measured Mass | Calculated Mass | Mass Error | MS/MS Fragmentation | Compound Name | Relative Area |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 4.62 | 237,310 | [M−H] | C9H8O3 | 163.0400 | 163.0395 | 0.5 | 163.0400, 119.0502, 93.0368 | 1.31% | |
| 2 | 6.18 | 324 | [M−H] | C25H24O12 | 515.1191 | 515.1190 | 0.1 | 353.0868, 91.0554, 179.0342, 135.0444 | Dicaffeoylquinic acid isomer a,d | 0.48% |
| 3 | 6.64 | 324 | [M−H] | C25H24O12 | 515.1193 | 515.1190 | 0.3 | 353.0871, 191.0555, 179.0343, 135.0445 | Dicaffeoylquinic acid a,d | 1.31% |
| 4 | 9.06 | 253,372 | [M−H] | C15H10O7 | 301.0365 | 301.0348 | 1.7 | 243.02886, 151.00304 | Quercetin a,c | 0.29% |
| 5 | 10.96 | 292 | [M−H] | C15H12O5 | 271.0613 | 271.0606 | 0.7 | 271.0613, 253.0504 | Pinobanksin a,c | 0.19% |
| 6 | 11.26 | 292 | [M−H] | C16H14O6 | 301.0714 | 301.0712 | 301.0714, 283.0603, 268.0367, 152.0107 | 4′-methoxy Pinobanksin a,e | 4.10% | |
| 7 | 11.40 | 265,365 | [M−H] | C15H10O6 | 285.0400 | 285.0399 | 0.1 | 285.0400, 227.03402 | Kaempferol a,b | 0.30% |
| 8 | 11.58 | 251,365 | [M−H] | C16H11O7 | 315.0505 | 315.0505 | 0 | 315.0505, 300.0266, 243.0292 | Quercetin-methyl ether a | 0.43% |
| 9 | 13.80 | 326 | [M−H] | C14H16O4 | 247.0971 | 247.0970 | 0.1 | 247.0971, 203.10683 | 5-isoprenyl caffeic acid a,f | 0.53% |
| 10 | 15.52 | 315 | [M−H] | C14H16O3 | 231.1025 | 231.1021 | 0.4 | 187.1121, 132.0575 | 3-isoprenyl- | 6.19% |
| 11 | 17.11 | 313 | [M−H] | C19H24O4 | 315.1597 | 315.1596 | 0.1 | 315.1597, 271.1692, 253.1591, 198.1043 | 3-hydroxy-2,2-dimethy-8-prenylchromane-6-propenoic a,e | 3.39% |
| 12 | 17.47 | 324 | [M−H] | C14H16O4 | 247.0971 | 247.0970 | 0.1 | 247.0971, 179.0341, 161.0236, 135.0443 | Caffeic acid isoprenyl ester a,c | 0.46% |
| 13 | 19.00 | 286 | [M−H] | C15H12O4 | 255.0662 | 255.0657 | 0.5 | 213.0552, 151.0031, 107.0134 | Pinocembrin a,c | 5.56% |
| 14 | 19.24 | 318 | [M−H] | C19H24O4 | 315.1597 | 315.1596 | 0.1 | 271.1675, 253.1589, 198.1041 | 3-hydroxy-2,2-dimethy-8-preylchromane-6-propenoic isomer a,e | 0.45% |
| 15 | 19.65 | 265,361 | [M−H] | C15H10O5 | 269.0456 | 269.0450 | 0.6 | 211.03914, 145.0288, 117.0340 | Galangin a,b | 0.53% |
| 16 | 20.35 | 265,365 | [M−H] | C16H11O6 | 299.0557 | 299.0556 | 0.1 | 284.0320, 151.0029, 107.0132 | Kaempferide a,c | 7.06% |
| 17 | 20.68 | 292 | [M−H] | C17H14O6 | 313.0745 | 313.0712 | 3.3 | 253.0505, 119.0498 | Pinobanksinr-3- | 0.37% |
| 18 | 21.18 | 269, 363 | [M−H] | C17H14O7 | 329.0665 | 329.0661 | 0.4 | 314.0424, 299.0180, 271.02431 | Quercetin-dimethyl ether a,c | 2.52% |
| 19 | 24.25 | 319 | [M−H] | C23H22O6 | 393.1343 | 393.1338 | 0.5 | 349.1436, 247.0967, 163.0392, 145.0289, 117.0340 | 5-isoprenyl caffeic acid- | 0.62% |
| 20 | 25.84 | 318 | [M−H] | C19H24O4 | 315.1600 | 315.1596 | 0.5 | 245.1170, 201.1279, 146.0731 | 3-hydroxy-2,2-dimethy-8-preylchromane-6-propenoic isomer a,e | 0.43% |
| 21 | 27.17 | 287 | [M−H] | C19H24O3 | 299.1647 | 299.1647 | 0 | 255.1748, 187.1117, 161.0601 | Diisoprenyl - | 4.49% |
| 22 | 32.88 | 314 | [M−H] | C19H24O3 | 299.1652 | 299.1647 | 0.5 | 255.1750, 201.1238, 145.0652 | Artepillin C (3,5-diisopentenyl-4-hydroxycinnamic acid) a,e | 35.68% |
| 23 | 38.36 | 279 | [M−H] | C23H24O4 | 363.1588 | 363.1596 | −0.8 | 231.1021, 187.1122, 149.0621 | 3-Prenyl-4-(dihydrocinnamoyloxy)-cinnamic acid a,d | 2.44% |
| 24 | 38.51 | 308 | [M−H] | C28H32O5 | 447.2175 | 447.2171 | 0.4 | 297.1492, 253.1592, 198.1041, 149.0603, 105.0704 | (E)-3-[2,3-dihydro-2-(1-methylethenyl)-7-prenyl-5-benzofuranyl]-2-propenoic acid a,d | 2.27% |
| 25 | 40.73 | - | [M−H] | C30H48O4 | 471.3485 | 471.3474 | 1.1 | 517.3542, 471.3485, 407.3318 | triterpenes | 0.94% |
| 26 | 42.48 | - | [M−H] | C30H46O4 | 469.3323 | 469.3318 | 0.5 | 515.3377, 469.3323, 423.3260 | triterpenes | 0.17% |
| 27 | 43.25 | - | [M−H] | C30H48O4 | 471.3480 | 471.3474 | 0.6 | 517.3436, 471.3481, 339.1994 | triterpenes | 0.24% |
| 28 | 43.68 | [M−H] | C30H46O4 | 469.3322 | 469.3318 | 0.4 | 515.3377, 469.3322, 407.3314 | triterpenes | 2.26% |
tR(min): retention time (min); λmax: the maximum absorption wavelength. a confirmed with MS fragmentation; b Confirmed with the standard; c confirmed with references [31]; d confirmed with references [32]; e confirmed with references [33]; f confirmed with references [34].
Figure 2MS/MS spectra under low energy (A) and high energy (B) of 5-isoprenyl caffeic acid p-coumaric acid ester.
Figure 3The fragmentation pathways of 5-isoprenyl caffeic acid p-coumaric acid ester.
Figure 4Influence of EEP-B on LPS-stimulated MACE growth. ## means extremely significant difference (p < 0.01) between LPS-stimulated group and control and ** means extremely significant difference (p < 0.01) between propolis treatment group and LPS-stimulated group.
Figure 5Effects of EEP-B on the levels of IL-6 and TNF-α. ## means extremely significant difference (p < 0.01) between LPS-stimulated group and control and ** means extremely significant difference (p < 0.01) between propolis treatment group and LPS-stimulated group.
Figure 6Effects of EEP-B on the levels of MCP-1, ICAM-1 and VCAM-1. (A). Protein expression of MCP-1, ICAM-1 and VCAM-1. (B). Relative expression of MCP-1, ICAM-1 and VCAM-1. ## means extremely significant difference (p < 0.01) between LPS-stimulated group and control, * means significant difference (p < 0.05) and ** means extremely significant difference (p < 0.01) between propolis treatment group and LPS-stimulated group.